Optical coherence tomography imaging of melanoma skin cancer.


Journal

Lasers in medical science
ISSN: 1435-604X
Titre abrégé: Lasers Med Sci
Pays: England
ID NLM: 8611515

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 26 07 2018
accepted: 22 11 2018
pubmed: 13 12 2018
medline: 26 3 2019
entrez: 13 12 2018
Statut: ppublish

Résumé

No consensus guidelines exist on the use of optical coherence tomography (OCT) for diagnosis of cutaneous melanoma. The objectives of this review are to provide a descriptive review of the literature on characteristics of cutaneous melanomas seen on high-definition OCT (HD-OCT), speckle variance OCT (SV-OCT), and conventional OCT and to compare their diagnostic ability with that of histopathology. A review of PubMed and Google Scholar identified all available literature on OCT in melanoma skin cancer that included all in vivo and ex vivo studies on human or human tissues and excluded all studies on non-human subjects or animal studies. Two hundred nine abstracts were considered for evaluation, 31 abstracts were selected for manuscript review, and 14 abstracts were included that met all criteria. Diagnoses of MIS and MM using HD-OCT and SV-OCT were consistently reported to correlate with histopathology. However, accuracy of diagnosis using conventional OCT varied. Most authors agreed that it was difficult to differentiate MM from benign nevi using conventional OCT. HD-OCT, SV-OCT, and conventional OCT show promise for visualizing cutaneous melanoma. The use of OCT in diagnosis of melanoma is rarely reported in the literature. There is a need to increase and standardize reporting of OCT for diagnosis of cutaneous melanoma.

Identifiants

pubmed: 30539405
doi: 10.1007/s10103-018-2696-1
pii: 10.1007/s10103-018-2696-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-420

Références

J Am Acad Dermatol. 2003 Nov;49(5):777-97; quiz 798-9
pubmed: 14576657
Exp Dermatol. 2005 Jan;14(1):56-9
pubmed: 15660920
J Am Acad Dermatol. 2007 Oct;57(4):629-37
pubmed: 17610989
Eur J Dermatol. 2008 Nov-Dec;18(6):617-31
pubmed: 18955194
J Am Acad Dermatol. 2009 May;60(5):719-35; quiz 736-8
pubmed: 19389517
J Biophotonics. 2009 Jul;2(6-7):442-51
pubmed: 19557752
Science. 1991 Nov 22;254(5035):1178-81
pubmed: 1957169
Opt Lett. 1988 Mar 1;13(3):186-8
pubmed: 19742022
Practitioner. 2009 Oct;253(1722):29-32, 3
pubmed: 19938560
Expert Rev Anticancer Ther. 2010 Mar;10(3):321-9
pubmed: 20214513
J Cutan Aesthet Surg. 2008 Jul;1(2):107-11
pubmed: 20300359
CA Cancer J Clin. 2010 Sep-Oct;60(5):301-16
pubmed: 20671054
Skin Res Technol. 2011 Aug;17(3):257-69
pubmed: 21342292
Lasers Surg Med. 2011 Mar;43(3):206-12
pubmed: 21412804
Dermatology. 2011;223(2):161-8
pubmed: 22024981
J Biomed Opt. 2013 Jun;18(6):061224
pubmed: 23314617
J Cancer Res Clin Oncol. 2013 Jul;139(7):1083-104
pubmed: 23552870
Arch Dermatol Res. 2014 Jan;306(1):11-26
pubmed: 23832144
Gastroenterol Res Pract. 2014;2014:376367
pubmed: 24719611
Br J Dermatol. 2014 Oct;171(4):799-805
pubmed: 24863700
J Eur Acad Dermatol Venereol. 2015 Mar;29(3):537-41
pubmed: 25073788
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):738-44
pubmed: 25175118
J Biophotonics. 2015 Aug;8(8):681-6
pubmed: 25237005
MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):591-6
pubmed: 26042651
G Ital Dermatol Venereol. 2015 Oct;150(5):603-15
pubmed: 26129683
J Am Acad Dermatol. 2015 Aug;73(2):315-7
pubmed: 26183975
J Eur Acad Dermatol Venereol. 2016 Oct;30(10):e67-e68
pubmed: 26370718
Arch Dermatol Res. 2016 Jan;308(1):7-20
pubmed: 26563265
Patient Relat Outcome Meas. 2015 Nov 06;6:229-42
pubmed: 26609248
Australas J Dermatol. 2016 Feb;57(1):72-3
pubmed: 26820787
Semin Cutan Med Surg. 2016 Mar;35(1):18-24
pubmed: 26963113
Dermatology. 2016;232(3):298-311
pubmed: 27104356
Dermatol Online J. 2016 Apr 18;22(4):
pubmed: 27617454
Dermatol Ther (Heidelb). 2017 Jun;7(2):187-202
pubmed: 28258554
JAMA Dermatol. 2017 Dec 1;153(12):1285-1291
pubmed: 29049424
J Biomed Opt. 2017 Dec;22(12):1-23
pubmed: 29274145
J Am Acad Dermatol. 1997 Dec;37(6):958-63
pubmed: 9418764
Curr Probl Dermatol. 1998;26:27-37
pubmed: 9597313

Auteurs

Ali Rajabi-Estarabadi (A)

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Julie M Bittar (JM)

Indiana University School of Medicine, Indianapolis, IN, USA.

Caiwei Zheng (C)

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Vanessa Nascimento (V)

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Isabella Camacho (I)

Georgetown University School of Medicine, Washington, DC, USA. ivc5@georgetown.edu.

Lynn G Feun (LG)

Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Mohammadreza Nasiriavanaki (M)

Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA.
Department of Dermatology, College of Engineering and School of Medicine Wayne State University, Detroit, MI, USA.
Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.

Michael Kunz (M)

Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.

Keyvan Nouri (K)

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH